Four answers to the DNA patent problem
There is a “profound tension” between exploiting biomarker patents and routine infringement of IP in laboratories, according to a report published this month
The report summarised discussions at a seminar convened by the UK's Human Genetics Commission in October last year. The seminar was attended by IP practitioners, researchers and surgeons.
The seminar was convened to collect views on the impact of DNA...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.